
Pathology Services Market Report 2026
Global Outlook – By Service Type ( Clinical Pathology, Anatomical Pathology, Molecular Pathology, Cytopathology, Forensic Pathology), By Test Type ( Blood Testing, Urine Testing, Tissue Biopsy Testing, Genetic Testing, Microbiological Testing, Immunological Testing), By Technology ( Laboratory Automation, Digital Pathology, Molecular Diagnostics Technologies, Artificial Intelligence And Data Analytics), By Application ( Disease Diagnosis, Drug Discovery And Development, Other Applications), By End User ( Hospitals, Diagnostic Laboratories, Research Institutions, Physician Offices, Homecare Settings) – Market Size, Trends, Strategies, and Forecast to 2030
Pathology Services Market Overview
• Pathology Services market size has reached to $33.78 billion in 2025 • Expected to grow to $47.79 billion in 2030 at a compound annual growth rate (CAGR) of 7.2% • Growth Driver: Expansion of Personalized and Precision Medicine Driving The Market Growth Due To Rising Adoption of Targeted Diagnostics and Therapies • Market Trend: Artificial Intelligence (AI)-Powered Digital Pathology Solutions Enhance Diagnostic Accuracy And Workflow Efficiency In Pathology Services • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Pathology Services Market?
Pathology services are specialized healthcare diagnostic services that analyze body fluids and other biological samples to detect and diagnose diseases and medical conditions. These services help physicians accurately identify illnesses, monitor disease progression, and determine appropriate treatment strategies. Pathology services play a vital role in detecting cancer, infections, genetic disorders, and chronic diseases while supporting preventive healthcare and precision medicine. The main service types of pathology services include clinical pathology, anatomical pathology, molecular pathology, cytopathology, and forensic pathology. Clinical pathology refers to laboratory medical services focused on analyzing bodily fluids such as blood, urine, and other samples to diagnose, monitor, and manage diseases. These services are categorized by test type including blood testing, urine testing, tissue biopsy testing, genetic testing, microbiological testing, and immunological testing and are enabled by technologies such as laboratory automation, digital pathology, molecular diagnostics technologies, and artificial intelligence and data analytics. The various applications involved are disease diagnosis, drug discovery and development, and others, and they are used by several end users such as hospitals, diagnostic laboratories, research institutions, physician offices, and homecare settings.
What Is The Pathology Services Market Size and Share 2026?
The pathology services market size has grown strongly in recent years. It will grow from $33.78 billion in 2025 to $36.14 billion in 2026 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to manual laboratory testing dependency, limited automation in diagnostic workflows, low adoption of molecular diagnostics, shortage of skilled laboratory professionals, fragmented healthcare laboratory infrastructure.What Is The Pathology Services Market Growth Forecast?
The pathology services market size is expected to see strong growth in the next few years. It will grow to $47.79 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to Ai-enabled diagnostic interpretation, expansion of precision medicine adoption, growth in cloud-based pathology platforms, increasing demand for preventive healthcare screening, integration of multi-omics and advanced molecular testing. Major trends in the forecast period include rising adoption of molecular and genetic testing for precision diagnostics, increasing shift toward integrated laboratory automation in pathology workflows, expansion of decentralized and point-of-care pathology testing services, growing demand for multi-omics-based disease detection approaches, increasing use of predictive analytics for early disease identification and monitoring.Global Pathology Services Market Segmentation
1) By Service Type: Clinical Pathology, Anatomical Pathology, Molecular Pathology, Cytopathology, Forensic Pathology 2) By Test Type: Blood Testing, Urine Testing, Tissue Biopsy Testing, Genetic Testing, Microbiological Testing, Immunological Testing 3) By Technology: Laboratory Automation, Digital Pathology, Molecular Diagnostics Technologies, Artificial Intelligence And Data Analytics 4) By Application: Disease Diagnosis, Drug Discovery And Development, Other Applications 5) By End User: Hospitals, Diagnostic Laboratories, Research Institutions, Physician Offices, Homecare Settings Subsegments: 1) By Clinical Pathology: Hematology Testing, Clinical Chemistry, Microbiology Testing, Immunology And Serology, Coagulation Testing, Urinalysis, Toxicology Testing, Blood Banking And Transfusion Services 2) By Anatomical Pathology: Histopathology, Surgical Pathology, Dermatopathology, Neuropathology, Gastrointestinal Pathology, Renal Pathology, Gynecological Pathology, Autopsy Pathology 3) By Molecular Pathology: Polymerase Chain Reaction (PCR) Testing, Next-Generation Sequencing (NGS), Genetic Testing, Companion Diagnostics, Infectious Disease Molecular Diagnostics, Oncology Molecular Diagnostics, Pharmacogenomics Testing, Prenatal Molecular Testing 4) By Cytopathology: Gynecologic Cytology, Non-Gynecologic Cytology, Fine Needle Aspiration (FNA) Cytology, Exfoliative Cytology, Liquid-Based Cytology, Urine Cytology, Respiratory Cytology, Breast Cytology 5) By Forensic Pathology: Postmortem Examination, Toxicological Analysis, Forensic Histopathology, Deoxyribonucleic Acid Profiling, Ballistic And Trauma Analysis, Sudden Death Investigation, Forensic Anthropology, Medico-Legal InvestigationWhat Is The Driver Of The Pathology Services Market?
The expansion of personalized and precision medicine is expected to propel the growth of the pathology services market going forward. Personalized and precision medicine refers to a healthcare approach that tailors disease prevention, diagnosis, and treatment to an individual's unique genetic, molecular, and clinical profile. The growing adoption of precision medicine is largely driven by rapid advancements in genomic sequencing technologies, which have significantly reduced the cost and time required to generate patient-specific genetic data, enabling broader clinical application across healthcare settings. The rising expansion of personalized and precision medicine boosts demand for pathology services as they are essential for performing the genetic testing, biomarker analysis, and molecular diagnostics that underpin individualized treatment decisions. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and healthcare organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. Therefore, the expansion of personalized and precision medicine is driving the growth of the pathology services industry.Key Players In The Global Pathology Services Market
Major companies operating in the pathology services market are Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Sonic Healthcare Limited, Charles River Laboratories International Inc., Healius Limited, ARUP Laboratories Inc., Apollo Diagnostics, Mayo Clinic Laboratories, Fulgent Genetics Inc., ACL Laboratories, Spectrum Healthcare Partners P.A., MedGenome Labs Ltd., ACM Global Laboratories Inc., Guangzhou KingMed Diagnostics Group Co. Ltd., Krsnaa Diagnostics Limited, Synnovis Group LLP, Dr Lal PathLabs, SYNLAB, UnilabsGlobal Pathology Services Market Trends and Insights
Major companies operating in the pathology services market are focusing on expanding artificial intelligence (AI)-powered digital pathology solutions to improve diagnostic precision, streamline laboratory workflows, and support pathologists in disease detection and analysis. AI-powered digital pathology solutions refer to advanced technologies that combine digital imaging, cloud-based platforms, and machine learning algorithms to assist in pathology interpretation, case review, and clinical decision-making. For instance, in February 2026, Laboratory Corporation of America Holdings, a US-based life sciences and diagnostic company, expanded its collaboration with PathAI, a US-based biotechnology company, to deploy the AISight Dx, an FDA-cleared digital pathology image management system, across its laboratory network. It supports digital pathology workflows through case management, slide annotation, real-time collaboration, and seamless integration with laboratory information systems. The platform combines AI-driven image analysis with secure and scalable infrastructure to improve diagnostic accuracy, reduce manual errors, and enhance operational efficiency.What Are Latest Mergers And Acquisitions In The Pathology Services Market?
In July 2024, Quest Diagnostics, a US-based provider of diagnostic information services, laboratory testing, and pathology services, acquired PathAI Diagnostics laboratory assets from PathAI for an undisclosed amount. With this acquisition, Quest Diagnostics aims to accelerate the adoption of artificial intelligence and digital pathology technologies to enhance cancer diagnosis and improve diagnostic efficiency and accuracy. PathAI is a US-based provider of digital and artificial intelligence-enabled pathology laboratory services focused on advancing precision diagnostics and supporting biopharmaceutical research and clinical applications.Regional Outlook
North America was the largest region in the pathology services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period.The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Pathology Services Market?
The pathology services market includes revenues earned by entities by providing services such as laboratory testing, diagnostic analysis, specimen collection, histopathology, and consultation services. The market value includes the value of related goods sold by the service provider or included within the service offering, such as diagnostic kits, reagents, and testing consumables. Only goods and services traded between entities or sold to end consumers are included.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Pathology Services Market Report 2026?
The pathology services market research report is one of a series of new reports from The Business Research Company that provides pathology services market statistics, including pathology services industry global market size, regional shares, competitors with a pathology services market share, detailed pathology services market segments, market trends and opportunities, and any further data you may need to thrive in the pathology services industry. This pathology services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.Pathology Services Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $36.14 billion |
| Revenue Forecast In 2030 | $47.79 billion |
| Growth Rate | CAGR of 7.2% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Service Type, Test Type, Technology, Application, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the pathology services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Sonic Healthcare Limited, Charles River Laboratories International Inc., Healius Limited, ARUP Laboratories Inc., Apollo Diagnostics, Mayo Clinic Laboratories, Fulgent Genetics Inc., ACL Laboratories, Spectrum Healthcare Partners P.A., MedGenome Labs Ltd., ACM Global Laboratories Inc., Guangzhou KingMed Diagnostics Group Co. Ltd., Krsnaa Diagnostics Limited, Synnovis Group LLP, Dr Lal PathLabs, SYNLAB, Unilabs |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
